Advertisement

TheBodyPRO.com Covers CROI 2016

News

Countries With Lower HIV Prevalence Have Lower Treatment Coverage

March 22, 2016

Low- and middle-income countries with adult HIV prevalence less than 5% had significantly lower rates of ART coverage in adults, pregnant women and children than those with higher prevalence. Lower prevalence countries also had a smaller percentage of women attending antenatal (ANC) visits and early infant diagnosis (EID) for infants.

Andrew Hill and colleagues from Liverpool University; Chelsea and Westminster Hospital; Imperial College; University of Oxford; World Health Organisation and UNITAID presented this analysis at CROI 2016.

They used data from the UNAIDS 2014 database that includes country-level information on epidemic size, HIV prevalence, ART coverage, ANC visits and EID. They noted that higher prevalence countries (at least 5%) are prioritised in PEPFAR and Global Fund ART programmes but 50% of HIV positive people live in lower prevalence countries.

Advertisement
Fifty-two low- and middle-income countries with at least 50,000 HIV positive people were included in the analysis: 40 with less than 5% HIV prevalence (total 16 million HIV positive) and 12 at least 5% HIV prevalence (total 16.1 million HIV positive).

The investigators used least squares linear regression to correlate adult HIV prevalence with estimated rates of ART coverage (adults, pregnant women and children), ANC, and EID. They weighted the analysis by epidemic size and controlled for GDP/capita and region (African vs non-African countries).

They found lower prevalence countries to have significantly lower rates of treatment coverage in adults, pregnant women and children, p<0.01 for each comparison. Lower prevalence countries also had a smaller percentage of women attending ANC visits and EID for infants than higher prevalence ones, p<0.01. See Table 1.


Table 1: ART Coverage in Lower vs Higher Prevalence Countries
CountriesLower Prevalence
(<5% HIV+ Adults)
Higher Prevalence
(>5% HIV+ Adults)
Number 40 12
HIV epidemic size 16 million 16.1 million
Adult HIV prevalence 1.6% 14.6%
Adults on ART 31.7% 48.3%
Children on ART 22.4% 42.6%
Pregnant women on ART 46.7% 89.1%
Pregnant women with > ANC 55.3% 68.1%
Infants received EID 20.1% 72.3%
Annual HIV death rate 4.5% 2.5%
Annual HIV transmission rate 6.2% 5.4%


The annual death rate for HIV positive people was 4.5% in the lower prevalence countries compared with 2.5% in the higher prevalence countries. The respective HIV transmission rates were 6.2% and 5.4%.

The investigators acknowledged a subset of lower prevalence countries with high rates of HIV testing and ART coverage eg Thailand, Rwanda, Vietnam and Dominican Republic. But many other lower prevalence countries need to prioritise HIV testing and ART for adults, pregnant women and children eg Russia, China, Nigeria, India and Pakistan, they wrote.


Reference

Hill A et al. Countries with lower HIV prevalence have lower ARV coverage: UNAIDS 2015 database. Conference on Retroviruses and Opportunistic Infections (CROI) 2016. 22-25 February 2016. Boston, Massachusetts. Poster abstract 1023.
www.croiconference.org/sessions/countries-lower-hiv-prevalence-have-lower-arv-coverage-unaids-2015-database (Abstract)




This article was provided by HIV i-Base. It is a part of the publication HIV Treatment Bulletin. Visit HIV i-Base's website to find out more about their activities, publications and services.
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.